000			04246nam a22004451i 4500
999			_c119174 _d119174 _x1
001			119174
003			ES-MaUEC
005			20230207040636.0
006			a|||| o|||| 00| 0
007			cr nn nnnaamaa
008			200212s2019 si | o |||| 0|eng d
020			_a9789811336423
024	7		_a10.1007/978-981-13-3642-3 _2doi
040			_aES-MaUEC _bspa _cES-MaUEC _dES-MaUEC
041	0		_aeng
050		4	_aRS199.5 _b2019 EB
245	0	0	_aNovel Drug Delivery Technologies : _bInnovative Strategies for Drug Re-positioning _cedited by Ambikanandan Misra, Aliasgar Shahiwala
250			_aFirst edition 2019
264		1	_aSingapore _bSpringer International Publishing _c2019
300			_a1 recurso en línea (XXIV, 431 páginas) _b62 ilustraciones, 40 ilustraciones a color
336			_2rdacontent _aTexto _btxt
337			_2rdamedia _aelectrónico _bc
338			_2rdacarrier _arecurso electrónico _bcr
347			_aArchivo de texto _bPDF
490	0		_aBiomedical and Life Sciences (Springer-11642)
505	0		_aChapter 1. Poorly water soluble drugs and formulation strategies to improve oral bioavailability -- Chapter 2. Buccal and intraoral drug delivery: Potential alternative to conventional therapy -- Chapter 3. Gastro-retentive drug delivery Systems: Current strategies and challenges -- Chapter 4. Peyer's patch: Targeted drug delivery for therapeutics benefits -- Chapter 5. Colonic drug delivery systems as Multi-unit potential: Therapeutic strategies and opportunities -- Chapter 6. Controlled and prolonged drug delivery systems: Therapeutics needs and formulation strategies -- Chapter 7. Transdermal drug administration: Emerging techniques and improved patient compliance -- Chapter 8. Inhalation drug therapy: Emerging trends in Nasal and pulmonary drug delivery -- Chapter 9. Ophthalmic and otic drug administration: Novel approaches and challenges -- Chapter 10. Targeted drug delivery to brain: Challenges and formulation approaches -- Chapter 11. Opportunities and challenges in targeted carrier based drug delivery: Increased efficacy & reduced toxicity.
520	3		_aThe application of drug delivery is a valuable, cost-effective lifecycle management resource. By endowing drugs with new and innovative therapeutic benefits, drug delivery systems extend products' profitable lifecycle, giving pharmaceutical companies competitive and financial advantages, and providing patients with improved medications. Formulation development is now being used to create new dosage forms for existing products, which not only reduces the time and expense involved in new drug development, but also helps with regard to patent protection and bypassing existing patents. Today's culture demands convenience, a major factor determining adherence to drug therapy. Over the past few years, patient convenience-oriented research in the field of drug delivery has yielded a range of innovative drug-delivery options. As a result, various drug-delivery systems, including medicated chewing gums, oral dispersible tablets, medicated lozenges and lollipops, have now hit the market and are very popular. These dosage forms offer a highly convenient way to dose medications, not only for special population groups with swallowing difficulties, such as children and the elderly, but for the general populace as well. This book provides valuable insights into a number of formulation design approaches that are currently being used, or could be used, to provide new benefits from existing drug molecules.
988			_aSpringer_BiomedLife_31032020
650		7	_2embne _aSistemas de liberación de fármacos _9667667
650		7	_2embne _aTecnología farmacéutica _9161127
700	1		_aMisra, Ambikanandan. _eeditor. _4edt _4http://id.loc.gov/vocabulary/relators/edt
700	1		_aShahiwala, Aliasgar. _eeditor. _4edt _4http://id.loc.gov/vocabulary/relators/edt
710	2		_aSpringerLink (Online service)
776	0	8	_iPrinted edition: _z9789811336416
776	0	8	_iPrinted edition: _z9789811336430
776	0	8	_iPrinted edition: _z9789811512735
856	4	0	_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=http://dx.doi.org/10.1007/978-981-13-3642-3
942			_2lcc _cLE _n0
998			_b04/2020 _dz _eb _zSI